enVVeno Medical Corporation 's (NASDAQ:NVNO) share price dropped 2% during trading on Monday . The company traded as low as $5.83 and last traded at $5.84. Approximately 8,978 shares were traded during trading, a decline of 74% from the average daily volume of 35,132 shares. The stock had previously closed at $5.96.
enVVeno Medical Trading Down 2.0 %
The stock has a 50 day simple moving average of $6.29 and a 200 day simple moving average of $5.48. The stock has a market cap of $55.32 million, a P/E ratio of -2.26 and a beta of 1.28.
Get enVVeno Medical alerts:
Institutional Investors Weigh In On enVVeno Medical
Large investors have recently modified their holdings of the business. Sepio Capital LP acquired a new stake in shares of enVVeno Medical during the 2nd quarter valued at $41,000. Dimensional Fund Advisors LP acquired a new stake in shares of enVVeno Medical during the 3rd quarter valued at $135,000. Arthur M. Cohen & Associates LLC boosted its holdings in shares of enVVeno Medical by 60.0% during the 2nd quarter. Arthur M. Cohen & Associates LLC now owns 24,000 shares of the company's stock valued at $91,000 after acquiring an additional 9,000 shares in the last quarter. UBS Oconnor LLC boosted its holdings in shares of enVVeno Medical by 26.8% during the 3rd quarter. UBS Oconnor LLC now owns 149,720 shares of the company's stock valued at $940,000 after acquiring an additional 31,607 shares in the last quarter. Finally, ACT Capital Management LLC boosted its holdings in shares of enVVeno Medical by 52.8% during the 1st quarter. ACT Capital Management LLC now owns 401,200 shares of the company's stock valued at $2,556,000 after acquiring an additional 138,700 shares in the last quarter. Institutional investors and hedge funds own 22.65% of the company's stock.
enVVeno Medical Company Profile
(Get Rating)
enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Read More
Get a free copy of the StockNews.com research report on enVVeno Medical (NVNO)
Santa Claus Rally? Here's What Needs to Happen
Is Ardelyx is A Buy After Slip in Early 2022
Will the Return of Bob Iger Return the Magic to Disney Stock?
Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Black Friday Deals on These 3 Dividend Plays
Receive News & Ratings for enVVeno Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enVVeno Medical and related companies with MarketBeat.com's FREE daily email newsletter.
エンビノ医療(ナスダックコード:NVNO)の株価は月曜日の取引で2%下落した。同社の取引価格は5.83ドルと低く、最終取引価格は5.84ドルだった。取引では約8,978株が成約し、35,132株の1日平均取引量より74%低下した。これまでの終値は5.96ドルだった。
EnVeno医療取引2.0%下落
この株の50日単純移動平均は6.29ドル,200日単純移動平均は5.48ドルであった。この株の時価は5532万ドル,市況率は−2.26,ベータ係数は1.28であった。
それを手に入れてEnVeno医療警報:
機関投資家はenVeno Medicalをよく見ている
大手投資家は最近、同社に対する持株を調整した。Sepio Capital LPは第2四半期にenVeno Medicalの新株式を買収し,41,000ドルの価値がある。Dimension Fund Advisors LPは第3四半期にenVVeno Medicalの新株式を買収し,13.5万ドルの価値がある。Arthur M.Cohen&Associates LLCは第2四半期に保有するenVVeno Medical株を60.0%増加させた。Arthur M.Cohen&Associates LLCは現在24,000株の同社株を保有しており,91,000ドルの価値があり,前四半期に9,000株増加した。瑞銀Oconnor LLCは第3四半期に26.8%のenVVeno Medical株を増資した。UBS Oconnor LLCは前四半期に31,607株を増資した後、現在149,720株の同社株を保有しており、940,000ドルの価値がある。最後に,ACT Capital Management LLCは第1四半期に52.8%のenVVeno Medical株を増資した。ACT Capital Management LLCは前四半期に138,700株増加した後,現在401,200株の同社株を保有しており,2,556,000ドルの価値がある。機関投資家とヘッジファンドは同社の22.65%の株を持っている。
EnVeno医療会社の概要
(格付けを取得する)
エンビノ医療会社(ナスダックコード:NVNO)は医療設備会社であり、革新的な生物プロテーゼ(組織ベース)装置の開発に専念し、静脈疾患治療の看護標準を高める。同社の主導製品であるVenoValveは一流の外科インプラントであり,重篤な深部静脈慢性機能不全(CVI)の治療のために開発されている。
もっと多くの内容を読む
StockNews.comのenVVeno Medical(NVNO)に関する研究報告を無料で取得する
サンタクロースラリー?次は起こるべきことです
Ardelyxは2022年初めに下落した後の購入ですか
ボブ·エグの復帰はマジックをディズニーの株に回帰させるのでしょうか?
テスラは現在2年間低い状態ですが、今はお得ですか?
この3つの配当活動のブラックフライデー取引
EnVeno医学日報のニュースと格付けを受ける-MarketBeat.comの無料毎日電子メール時事通信を介して、enVVeno Medicalおよび関連会社の最新のニュースおよびアナリスト格付けの毎日の簡単な要約を受信するために、以下に電子メールアドレスを入力します。